These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38062852)

  • 21. New experimental models of the blood-brain barrier for CNS drug discovery.
    Kaisar MA; Sajja RK; Prasad S; Abhyankar VV; Liles T; Cucullo L
    Expert Opin Drug Discov; 2017 Jan; 12(1):89-103. PubMed ID: 27782770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MMP-9 gene silencing by a quantum dot-siRNA nanoplex delivery to maintain the integrity of the blood brain barrier.
    Bonoiu A; Mahajan SD; Ye L; Kumar R; Ding H; Yong KT; Roy I; Aalinkeel R; Nair B; Reynolds JL; Sykes DE; Imperiale MA; Bergey EJ; Schwartz SA; Prasad PN
    Brain Res; 2009 Jul; 1282():142-55. PubMed ID: 19477169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The blood-brain barrier in neuroimmunology: Tales of separation and assimilation.
    Banks WA
    Brain Behav Immun; 2015 Feb; 44():1-8. PubMed ID: 25172555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of Acute, High-dose Cadmium Exposure with Alterations in Vascular Endothelial Barrier Antigen Expression and Astrocyte Morphology in the Developing Rat Central Nervous System.
    Ibiwoye MO; Matthews Q; Travers K; Foster JD
    J Comp Pathol; 2019 Oct; 172():37-47. PubMed ID: 31690413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood-brain barrier structure and function and the challenges for CNS drug delivery.
    Abbott NJ
    J Inherit Metab Dis; 2013 May; 36(3):437-49. PubMed ID: 23609350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cadmium and its neurotoxic effects.
    Wang B; Du Y
    Oxid Med Cell Longev; 2013; 2013():898034. PubMed ID: 23997854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nontoxic amphiphilic carbon dots as promising drug nanocarriers across the blood-brain barrier and inhibitors of β-amyloid.
    Zhou Y; Liyanage PY; Devadoss D; Rios Guevara LR; Cheng L; Graham RM; Chand HS; Al-Youbi AO; Bashammakh AS; El-Shahawi MS; Leblanc RM
    Nanoscale; 2019 Nov; 11(46):22387-22397. PubMed ID: 31730144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gut reactions: How the blood-brain barrier connects the microbiome and the brain.
    Logsdon AF; Erickson MA; Rhea EM; Salameh TS; Banks WA
    Exp Biol Med (Maywood); 2018 Jan; 243(2):159-165. PubMed ID: 29169241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selecting Good 'Drug-Like' Properties to Optimize Small Molecule Blood-Brain Barrier Penetration.
    Trippier PC
    Curr Med Chem; 2016; 23(14):1392-407. PubMed ID: 27048339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crossing the blood-brain-barrier with transferrin conjugated carbon dots: A zebrafish model study.
    Li S; Peng Z; Dallman J; Baker J; Othman AM; Blackwelder PL; Leblanc RM
    Colloids Surf B Biointerfaces; 2016 Sep; 145():251-256. PubMed ID: 27187189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Applications of nanotechnology in drug delivery to the central nervous system.
    Saeedi M; Eslamifar M; Khezri K; Dizaj SM
    Biomed Pharmacother; 2019 Mar; 111():666-675. PubMed ID: 30611991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain meets body: the blood-brain barrier as an endocrine interface.
    Banks WA
    Endocrinology; 2012 Sep; 153(9):4111-9. PubMed ID: 22778219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nano carriers for drug transport across the blood-brain barrier.
    Li X; Tsibouklis J; Weng T; Zhang B; Yin G; Feng G; Cui Y; Savina IN; Mikhalovska LI; Sandeman SR; Howel CA; Mikhalovsky SV
    J Drug Target; 2017 Jan; 25(1):17-28. PubMed ID: 27126681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrating in Silico and in Vitro Approaches To Predict Drug Accessibility to the Central Nervous System.
    Zhang YY; Liu H; Summerfield SG; Luscombe CN; Sahi J
    Mol Pharm; 2016 May; 13(5):1540-50. PubMed ID: 27015243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent advances in blood-brain barrier disruption as a CNS delivery strategy.
    Bellavance MA; Blanchette M; Fortin D
    AAPS J; 2008; 10(1):166-77. PubMed ID: 18446517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does VEGF secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight-junction proteins in central nervous system leukemia?
    Feng S; Huang Y; Chen Z
    Med Hypotheses; 2011 May; 76(5):618-21. PubMed ID: 21398042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Translocation and neurotoxicity of CdTe quantum dots in RMEs motor neurons in nematode Caenorhabditis elegans.
    Zhao Y; Wang X; Wu Q; Li Y; Wang D
    J Hazard Mater; 2015; 283():480-9. PubMed ID: 25464286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.
    Begley DJ
    Pharmacol Ther; 2004 Oct; 104(1):29-45. PubMed ID: 15500907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blood-brain barrier permeation and efflux exclusion of anticholinergics used in the treatment of overactive bladder.
    Chancellor MB; Staskin DR; Kay GG; Sandage BW; Oefelein MG; Tsao JW
    Drugs Aging; 2012 Apr; 29(4):259-73. PubMed ID: 22390261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strategies for transporting nanoparticles across the blood-brain barrier.
    Zhang TT; Li W; Meng G; Wang P; Liao W
    Biomater Sci; 2016 Feb; 4(2):219-29. PubMed ID: 26646694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.